Inhibrx Stock Odds of Future Stock Price Finishing Over 40.43

INBX -  USA Stock  

USD 40.43  0.28  0.70%

Inhibrx's future price is the expected price of Inhibrx instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Inhibrx performance during a given time horizon utilizing its historical volatility. Price to Book Value is likely to drop to 14.74 in 2021. Price to Earnings Ratio is likely to drop to -10.64 in 2021.

Inhibrx Price Probability 

 
Refresh
Please see Inhibrx Backtesting, Inhibrx Valuation, Inhibrx Correlation, Inhibrx Hype Analysis, Inhibrx Volatility, Inhibrx History as well as Inhibrx Performance. Please specify Inhibrx time horizon, a valid symbol (red box) and a target price (blue box) you would like Inhibrx odds to be computed.
Apply Odds

Inhibrx Target Price Odds to finish over 40.43

The tendency of Inhibrx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for foresting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 40.43 90 days 40.43  about 27.3
Based on a normal probability distribution, the odds of Inhibrx to move above the current price in 90 days from now is about 27.3 (This Inhibrx probability density function shows the probability of Inhibrx Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Inhibrx has a beta of 0.92. This usually indicates Inhibrx market returns are sensitive to returns on the market. As the market goes up or down, Inhibrx is expected to follow. Additionally The company has an alpha of 0.5997, implying that it can generate a 0.6 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Inhibrx Price Density 
      Price 

Predictive Modules for Inhibrx

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inhibrx. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inhibrx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inhibrx in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
32.5437.3342.12
Details
Intrinsic
Valuation
LowReal ValueHigh
34.5047.8652.65
Details
Naive
Forecast
LowNext ValueHigh
34.7139.4944.28
Details
3 Analysts
Consensus
LowTarget PriceHigh
50.0052.6755.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inhibrx. Your research has to be compared to or analyzed against Inhibrx's peers to derive any actionable benefits. When done correctly, Inhibrx's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inhibrx.

Inhibrx Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Inhibrx is not an exception. The market had few large corrections towards the Inhibrx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Inhibrx, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Inhibrx within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.60
β
Beta against DOW0.92
σ
Overall volatility
5.25
Ir
Information ratio 0.13

Inhibrx Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Inhibrx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Inhibrx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Inhibrx appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 12.9 M. Net Loss for the year was (75.32 M) with loss before overhead, payroll, taxes, and interest of (60.61 M).
Inhibrx currently holds about 107.99 M in cash with (62.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86.
Inhibrx has a poor financial position based on the latest SEC disclosures
Roughly 40.0% of the company shares are held by company insiders
Latest headline from www.nasdaq.com: Amryt Skin Disorder NDA Review Gets 3 Months Extension - Nasdaq

Inhibrx Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Inhibrx Stock often depends not only on the future outlook of the current and potential Inhibrx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inhibrx's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.06%
Short Percent Of Float3.47%
Float Shares17.36M
Shares Short Prior Month837.14k
Average Daily Volume Last 10 Day119.7k
Average Daily Volume In Three Month192.09k
Date Short Interest28th of May 2021

Inhibrx Technical Analysis

Inhibrx's future price can be derived by breaking down and analyzing its technical indicators over time. Inhibrx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Inhibrx. In general, you should focus on analyzing Inhibrx Stock price patterns and their correlations with different microeconomic environments and drivers.

Inhibrx Predictive Forecast Models

Inhibrx time-series forecasting models is one of many Inhibrx's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inhibrx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Inhibrx

Checking the ongoing alerts about Inhibrx for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Inhibrx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Inhibrx Alerts

Inhibrx Alerts and Suggestions

Inhibrx appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 12.9 M. Net Loss for the year was (75.32 M) with loss before overhead, payroll, taxes, and interest of (60.61 M).
Inhibrx currently holds about 107.99 M in cash with (62.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86.
Inhibrx has a poor financial position based on the latest SEC disclosures
Roughly 40.0% of the company shares are held by company insiders
Latest headline from www.nasdaq.com: Amryt Skin Disorder NDA Review Gets 3 Months Extension - Nasdaq
Please see Inhibrx Backtesting, Inhibrx Valuation, Inhibrx Correlation, Inhibrx Hype Analysis, Inhibrx Volatility, Inhibrx History as well as Inhibrx Performance. Note that the Inhibrx information on this page should be used as a complementary analysis to other Inhibrx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Inhibrx Stock analysis

When running Inhibrx price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Is Inhibrx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibrx. If investors know Inhibrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibrx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inhibrx is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx's value that differs from its market value or its book value, called intrinsic value, which is Inhibrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx's market value can be influenced by many factors that don't directly affect Inhibrx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx's value and its price as these two are different measures arrived at by different means. Investors typically determine Inhibrx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.